Development of highly potent and selective diaminothiazole inhibitors of cyclin-dependent kinases.
Schonbrunn, E., Betzi, S., Alam, R., Martin, M.P., Becker, A., Han, H., Francis, R., Chakrasali, R., Jakkaraj, S., Kazi, A., Sebti, S.M., Cubitt, C.L., Gebhard, A.W., Hazlehurst, L.A., Tash, J.S., Georg, G.I.(2013) J Med Chem 56: 3768-3782
- PubMed: 23600925 
- DOI: 10.1021/jm301234k
- Primary Citation of Related Structures:  
3SQQ, 4GCJ, 3RJC, 3RKB, 3RK5, 3RK7, 3RK9, 3RMF, 3RNI, 3S0O - PubMed Abstract: 
Cyclin-dependent kinases (CDKs) are serine/threonine protein kinases that act as key regulatory elements in cell cycle progression. We describe the development of highly potent diaminothiazole inhibitors of CDK2 (IC50 = 0.0009-0.0015 μM) from a single hi ...